Home/Filings/4/0000950170-25-109815
4//SEC Filing

Podlesak Dennis 4

Accession 0000950170-25-109815

CIK 0001395937other

Filed

Aug 17, 8:00 PM ET

Accepted

Aug 18, 5:02 PM ET

Size

20.3 KB

Accession

0000950170-25-109815

Insider Transaction Report

Form 4
Period: 2025-08-14
Transactions
  • Exercise/Conversion

    Stock Options (Right to buy)

    2025-08-1514,4000 total
    Exercise: $7.20Exp: 2025-08-18Common Stock (14,400 underlying)
  • Exercise/Conversion

    Stock Options (Right to buy)

    2025-08-1819,2000 total
    Exercise: $7.20Exp: 2025-08-20Common Stock (19,200 underlying)
  • Sale

    Common Stock

    2025-08-14$14.19/sh19,200$272,521191,763 total
  • Sale

    Common Stock

    2025-08-18$15.84/sh19,200$304,170191,763 total
  • Sale

    Common Stock

    2025-08-15$15.54/sh19,200$298,408191,763 total
  • Exercise/Conversion

    Common Stock

    2025-08-15$7.20/sh+19,200$138,240210,963 total
  • Exercise/Conversion

    Stock Options (Right to buy)

    2025-08-154,8000 total
    Exercise: $7.20Exp: 2025-08-20Common Stock (4,800 underlying)
  • Exercise/Conversion

    Common Stock

    2025-08-14$7.20/sh+19,200$138,240210,963 total
  • Exercise/Conversion

    Common Stock

    2025-08-18$7.20/sh+19,200$138,240210,963 total
  • Exercise/Conversion

    Stock Options (Right to buy)

    2025-08-1419,2000 total
    Exercise: $7.20Exp: 2025-08-18Common Stock (19,200 underlying)
Footnotes (5)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person solely covering equity grants with expiration dates prior to August 21, 2025. Following the sales reported in this Form 4, the Reporting Person has a total of 135,000 options to purchase shares of common stock that are vested and immediately exercisable and no unvested options to purchase shares of common stock.
  • [F2]The sale prices ranged from $13.30 to $14.80.
  • [F3]The sale prices ranged from $14.88 to $15.91.
  • [F4]The sale prices ranged from $15.61 to $16.00.
  • [F5]This option is fully vested.

Documents

1 file

Issuer

Syndax Pharmaceuticals Inc

CIK 0001395937

Entity typeother

Related Parties

1
  • filerCIK 0001314595

Filing Metadata

Form type
4
Filed
Aug 17, 8:00 PM ET
Accepted
Aug 18, 5:02 PM ET
Size
20.3 KB